MLchartDataset catalogue

Infugem

Term · Oncology and biomedicine · MLC-T-ONC-004318

A drug used alone or with other drugs to treat certain types of breast, non-small cell lung, ovarian, and pancreatic cancers that are advanced or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Infugem stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called gemcitabine hydrochloride and Gemzar.

Table 1. Record
IdentifierMLC-T-ONC-004318
FieldOncology and biomedicine
Synonymsgemcitabine hydrochloride; Gemzar
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004318",
  "term": "Infugem",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat certain types of breast, non-small cell lung, ovarian, and pancreatic cancers that are advanced or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Infugem stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called gemcitabine hydrochloride and Gemzar.",
  "synonyms": [
    "gemcitabine hydrochloride",
    "Gemzar"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/infugem/"
}

Record 9,259 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.